+16.6%
EMR vs THC
+40.9%
-24.2%
-23.4%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | THC | Excess | Alpha |
|---|---|---|---|---|
| 1D | +1.7% | +0.6% | +1.1% | +1.7% |
| 7D | -1.5% | -0.7% | -0.9% | -1.5% |
| 30D | -5.6% | +1.3% | -6.9% | -5.8% |
| 3M | +7.9% | +64.2% | -56.3% | +2.9% |
| 6M | +6.0% | +8.3% | -2.2% | +2.7% |
| YTD | +16.4% | +33.4% | -16.9% | +13.7% |
| 1Y | +16.6% | +37.7% | -21.1% | +11.5% |
| All | +16.6% | +40.9% | -24.2% | +11.5% |
Cumulative growth
Daily Returns
Daily percentage return beside THC.
Daily Out/Under-Performance
Portfolio return minus THC return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × THC return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded THC wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling